Importance of the Brain Angiotensin System in Parkinson’s Disease

Hepatocyte Growth Factor (HGF): Neurotrophic Functions and Therapeutic Implications for Neuronal Injury/Diseases

(2012) Hiroshi Funakoshi et al.   Current Signal Transduction Therapy

Stromal factors SDF1α, sFRP1, and VEGFD induce dopaminergic neuron differentiation of human pluripotent stem cells

(2012) Catherine M. Schwartz et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Genetic Rat Models of Parkinson's Disease

(2012) Ryan M. Welchko et al.   Parkinsons Disease

Dopaminergic neuroprotection of hormonal replacement therapy in young and aged menopausal rats: role of the brain angiotensin system

(2011) A. I. Rodriguez-Perez et al.   BRAIN

Experimental and Clinical Application of Plasmid DNA in the Field of Central Nervous Diseases

(2011) Munehisa Shimamura et al.   CURRENT GENE THERAPY

The neuroprotective action of candesartan is related to interference with the early stages of 6-hydroxydopamine-induced dopaminergic cell death

(2011) Birgit Mertens et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Renin angiotensin system and gender differences in dopaminergic degeneration

(2011) Ana I Rodriguez-Perez et al.   Molecular Neurodegeneration

Priorities in Parkinson's disease research

(2011) Wassilios G. Meissner et al.   NATURE REVIEWS DRUG DISCOVERY

Parkinson’s disease: The non-motor issues

(2011) K. Ray Chaudhuri et al.   PARKINSONISM & RELATED DISORDERS

l-DOPA: A scapegoat for accelerated neurodegeneration in Parkinson's disease?

(2011) Janusz Lipski et al.   PROGRESS IN NEUROBIOLOGY

Brain renin-angiotensin—A new look at an old system

(2011) John W. Wright et al.   PROGRESS IN NEUROBIOLOGY

Hepatocyte Growth Factor in Synaptic Plasticity and Alzheimer's Disease

(2011) Shiv K. Sharma   TheScientificWorldJOURNAL

Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson’s disease

(2010) Begoña Villar-Cheda et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Estrogen and angiotensin interaction in the substantia nigra. Relevance to postmenopausal Parkinson's disease

(2010) Ana I. Rodriguez-Perez et al.   EXPERIMENTAL NEUROLOGY

Expression of hepatocyte growth factor in the serum and cerebrospinal fluid of patients with Parkinson’s disease

(2010) Zivar Salehi et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Strong neurogenesis, angiogenesis, synaptogenesis, and antifibrosis of hepatocyte growth factor in rats brain after transient middle cerebral artery occlusion

(2010) Jingwei Shang et al.   JOURNAL OF NEUROSCIENCE RESEARCH

The Angiotensin IV Analog Nle-Tyr-Leu- -(CH2-NH2)3-4-His-Pro-Phe (Norleual) Can Act as a Hepatocyte Growth Factor/c-Met Inhibitor

(2010) B. J. Yamamoto et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Mitochondrial dysfunction: A potential link between neuroinflammation and neurodegeneration?

(2010) Maarten E. Witte et al.   MITOCHONDRION

Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration

(2010) Begoña Villar-Cheda et al.   NEUROBIOLOGY OF AGING

The discovery of Hepatocyte Growth Factor (HGF) and its significance for cell biology, life sciences and clinical medicine

(2010) Toshikazu NAKAMURA et al.   PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

The inflammatory response in the MPTP model of Parkinson’s disease is mediated by brain angiotensin: relevance to progression of the disease

(2009) Belen Joglar et al.   JOURNAL OF NEUROCHEMISTRY

Glutamate Controls Growth Rate and Branching of Dopaminergic Axons

(2009) Y. Schmitz et al.   JOURNAL OF NEUROSCIENCE

The role of the central renin-angiotensin system in Parkinson’s disease

(2009) Birgit Mertens et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

(2009) K Ray Chaudhuri et al.   LANCET NEUROLOGY

Gene knockout of insulin-regulated aminopeptidase: Loss of the specific binding site for angiotensin IV and age-related deficit in spatial memory

(2009) Anthony L. Albiston et al.   NEUROBIOLOGY OF LEARNING AND MEMORY

Etiology and Pathogenesis of Parkinson Disease

(2009) Anthony H.V. Schapira   NEUROLOGIC CLINICS

USE OF ANTIHYPERTENSIVES AND THE RISK OF PARKINSON DISEASE

(2009) A. Ascherio et al.   NEUROLOGY

The scientific and clinical basis for the treatment of Parkinson disease (2009)

(2009) C. W. Olanow et al.   NEUROLOGY

Ang II and Ang IV: Unraveling the Mechanism of Action on Synaptic Plasticity, Memory, and Epilepsy

(2008) Dimitri De Bundel et al.   CNS Neuroscience & Therapeutics

A case of parkinsonism worsened by losartan: A probable new adverse effect

(2008) G.R.K. Sarma et al.   MOVEMENT DISORDERS

Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study

(2008) Pedro J. García Ruiz et al.   MOVEMENT DISORDERS

Drug development of MET inhibitors: targeting oncogene addiction and expedience

(2008) Paolo M. Comoglio et al.   NATURE REVIEWS DRUG DISCOVERY

Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS

(2008) J. Rodriguez-Pallares et al.   NEUROBIOLOGY OF DISEASE

Use of antihypertensives and the risk of Parkinson disease

(2008) C. Becker et al.   NEUROLOGY

Hepatocyte growth factor promotes proliferation and migration in immortalized progenitor cells

(2008) Feng Lan et al.   NEUROREPORT

Aging effects on the dopamine transporter expression and compensatory mechanisms

(2007) Ignacio Cruz-Muros et al.   NEUROBIOLOGY OF AGING

Angiotensin receptor subtype mediated physiologies and behaviors: New discoveries and clinical targets

(2007) J WRIGHT et al.   PROGRESS IN NEUROBIOLOGY